We can't find the internet
Attempting to reconnect
10278.1;9 PFDP-LS
Synthetic Virus-Like Particles (SVLPs): A new Approach to Synthetic Vaccines and Nanomedicine
Zusammenfassung
Synthetic Virus-Like Particles (SVLPs): A new Approach to Synthetic Vaccines and Nanomedicine
Weitere Texte
Abstract
This Discovery grant should support the launch of the start-up (spin-out) company Virometix AG. The company will exploit a fundamentally new approach for the rational design and production of immuno-therapeutic drugs and vaccines using the tools of chemistry. The so-called SVLP technology provides a breakthrough in the creation of nanoscale biological assemblies for multivalent display of epitope mimetics. A new generation of synthetic vaccines will be developed using this technology to combat infectious and chronic human diseases. The technology is based on the use of virus-like particles made using artificial, fully synthetic building blocks, to deliver target antigens to cells in the immune system.
Beteiligte
John A. Robinson
Kontaktperson
robinson@oci.uzh.ch
Universität Zürich Organisch-chemisches Institut John A. Robinson Winterthurerstr. 190 8057 Zürich ZH CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2009-09-30
- Enddatum
- 2012-03-13
- Bewilligte Gesamtkosten
- CHF 754372.00
- Sektion
- 19 Förderbereich GL
- NABS Politikbereich
- Nicht aufteilbare / nicht zuteilbare Forschung
Forschungsdisziplinen
- T490 Biotechnology 100.0%